- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03166579
Effectiveness Evaluation of 'The Endeavour Programme'
Evaluating the Effectiveness of 'The Endeavour Programme': DBT for Irish Adults With Borderline Personality Disorder
This study aims to evaluate the effectiveness of Dialectical Behaviour Therapy for adults with Borderline Personality Disorder attending Community Mental Health Services in Cork, Ireland.
The main objective of the current study is to determine if completion of a 12 month DBT programme is associated with improved outcomes in terms of borderline symptoms, anxiety, hopelessness, suicidal behaviour, depression and quality of life.
A secondary objective includes assessing client progress across multiple time-points throughout the treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dialectical Behaviour Therapy (DBT) is noted to be an intervention with a growing evidence base which demonstrates its effectiveness in treating individuals with Borderline Personality Disorder (BPD). Nine randomised controlled trials have been completed at six independent sites. These trials have found a reduction in suicidal behaviours, intentional self-injury, depression, hopelessness and other difficulties associated with this mental health diagnosis.
While the efficacy of DBT has been demonstrated through multiple RCTs, few studies have examined the effectiveness of DBT in community mental health settings. In particular, no study to our knowledge has evaluated the standard 12-month DBT programme for adults with BPD in an Irish community setting. "Standard" DBT is delivered by a team of multidisciplinary mental health professionals, and comprises of individual therapy sessions for each patient, group skills training sessions, phone coaching and consultation meetings for the clinicians on the DBT team.
The current study thus aims to evaluate the effectiveness of the standard 12-month DBT programme (The Endeavour Programme) in an Irish community setting.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Meet criteria for diagnosis of either Borderline Personality Disorder (DSM IV/V) or Emotionally Unstable Personality Disorder (ICD-10)
- Current emotion and behavioural dysregulation
- A history of self-harm behaviour
- The client will have discussed the diagnosis with a member of the DBT team and will have expressed an interest in, and commitment to the 12 month programme.
Exclusion Criteria:
- An active psychosis
- If the client has severe developmental delays, cognitive impairment or learning disabilities (exceeding mild range)
- If a clients' substance/drug dependence, eating disorder or any other mental health issue/behaviour is at such a level that it would impede their engaging with any of the modalities of DBT
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dialectical Behaviour Therapy
Participants receive the "standard" 12 month DBT programme where all four modes of treatment are delivered including: individual therapy, group skills training, telephone coaching and DBT team consultation.
|
Dialectical Behaviour Therapy (DBT) is a psychological intervention which was originally developed for women with Borderline Personality Disorder.
DBT is delivered by a team of multidisciplinary mental health professionals, and comprises of individual therapy sessions for each patient, group skills training sessions, phone coaching and consultation meetings for the clinicians on the DBT team.
Group skills are delivered in blocks of three modules which teach mindfulness, distress tolerance, emotion regulation and interpersonal effectiveness.
The three modules are delivered over a 24-week period and are then repeated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Borderline Symptoms
Time Frame: 12 months from pre-intervention to post-intervention
|
Borderline Symptom List (BSL-23).
The BSL-23 is a self-report questionnaire which comprises 23 items measuring borderline-typical symptomatology.
|
12 months from pre-intervention to post-intervention
|
Suicidal ideation
Time Frame: 12 months from pre-intervention to post-intervention
|
Beck Scale for Suicide Ideation (BSS).
The BSS is a 21-item self-report assessment developed to identify individuals at risk of suicide.
|
12 months from pre-intervention to post-intervention
|
Hopelessness
Time Frame: 12 months from pre-intervention to post-intervention
|
Beck Hopelessness Scale (BHS).
The BHS is a 20 item self-report measure which assesses key aspects of hopelessness.
|
12 months from pre-intervention to post-intervention
|
Depression
Time Frame: 12 months from pre-intervention to post-intervention
|
Beck Depression Inventory - Second Edition (BDI-II).
The BDI-II is a 21 item self-report measure of symptoms and attitudes related to depression.
|
12 months from pre-intervention to post-intervention
|
Anxiety
Time Frame: 12 months from pre-intervention to post-intervention
|
Beck Anxiety Inventory (BAI).
The BAI is a 21 is self-report multiple choice survey which evaluates both physiological and cognitive symptoms of anxiety
|
12 months from pre-intervention to post-intervention
|
Quality of Life
Time Frame: 12 months from pre-intervention to post-intervention
|
World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF).
The WHOQOL-BREF was developed collaboratively in a number of centres to act as an international cross-culturally comparable quality of life assessment.
It comprises 26 items across four domains: physical health (domain 1), psychological health (domain 2), social relationships (domain 3), and environment (domain 4).
|
12 months from pre-intervention to post-intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Daniel Flynn, PGDip, Psychology Manager
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NOSP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Personality Disorder, Borderline
-
University Hospital, Basel, SwitzerlandLeading House for the Latin American Region (Seed Money Grant SMG 1730)WithdrawnBorderline Personality Disorder (BPD)
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline
-
University of EdinburghRecruitingEmotionally Unstable Personality Disorder, Borderline TypeUnited Kingdom
-
Hospital Universitari Vall d'Hebron Research InstituteUnknownBorderline Personality Disorder.Spain
-
Silvia Elisa Hurtado SantiagoCompletedPersonality Disorder, BorderlineSpain
-
Universitat Jaume IHospital de la RiberaNot yet recruitingBorderline Personality Disorder (BPD)Spain
-
University of OldenburgProf. René Hurlemann; Jella Voelter, M.Sc.RecruitingBorderline Personality Disorder (BPD)Germany
-
NHS Greater Glasgow and ClydeUnknownBorderline Personality Disorder (BPD) | Antisocial Personality Disorder (ASPD)United Kingdom
-
Rutgers, The State University of New JerseyActive, not recruitingBorderline Personality Disorder in AdolescenceUnited States
-
Norwegian University of Science and TechnologyCompletedPersonality Disorder, Borderline | Avoidant Personality DisorderNorway
Clinical Trials on Dialectical Behaviour Therapy
-
Health Service Executive, IrelandCompletedPersonality Disorder, Borderline
-
University of ManitobaCompleted
-
Hospital General Universitario Gregorio MarañonCompleted
-
University of ExeterCompletedBipolar DisorderUnited Kingdom
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; St. Olavs Hospital; Nordlandssykehuset... and other collaboratorsRecruitingBorderline Personality Disorder | Self HarmNorway
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR); Simon Fraser UniversityActive, not recruitingBorderline Personality DisorderCanada
-
Dr. Jessica JonesProvidence CareCompletedIntellectual DisabilityCanada
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR); Unity Health TorontoCompleted
-
Umeå UniversityActive, not recruitingAnorexia Nervosa | Anorexia in Adolescence | Anorexia Nervosa, AtypicalSweden
-
Norwegian University of Science and TechnologyOslo University Hospital; Møre og Romsdal Hospital TrustRecruitingSuicide | Post Traumatic Stress Disorder | Substance Use Disorders | Emotion Regulation | Self-harmNorway